Absorption |
Blood-Brain Barrier | BBB+ | 0.8626 |
Human Intestinal Absorption | HIA+ | 0.9936 |
Caco-2 Permeability | Caco2- | 0.5779 |
P-glycoprotein Substrate | Substrate | 0.5140 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9576 |
Non-inhibitor | 0.8990 |
Renal Organic Cation Transporter | Non-inhibitor | 0.7771 |
Distribution |
Subcellular localization | Mitochondria | 0.7532 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7460 |
CYP450 2D6 Substrate | Non-substrate | 0.8622 |
CYP450 3A4 Substrate | Non-substrate | 0.5443 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9637 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9644 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9372 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9439 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9393 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7707 |
Non-inhibitor | 0.8898 |
AMES Toxicity | Non AMES toxic | 0.7163 |
Carcinogens | Non-carcinogens | 0.8667 |
Fish Toxicity | Low FHMT | 0.9158 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8357 |
Honey Bee Toxicity | Low HBT | 0.7977 |
Biodegradation | Not ready biodegradable | 0.5594 |
Acute Oral Toxicity | III | 0.7757 |
Carcinogenicity (Three-class) | Non-required | 0.6578 |